SEC Form 4 · accession 0001193125-26-274257
KESTRA MEDICAL TECHNOLOGIES, LTD. · KMTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Daniel Webster
Officer — See Remarks · Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001877184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Jun 15, 2026 | S | 15,000 | $20.8095 | D | 395,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- F2The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.5400 to $21.3900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Remarks
President and Chief Executive Officer